© Reuters. FILE PHOTO: Signage is seen exterior of a Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York Metropolis, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Picture
(Reuters) -Walgreens Boots Alliance mentioned on Thursday that it anticipated to chop a minimum of $1 billion in prices in 2024 as a part of its ongoing efforts, which embody shutting unprofitable shops, after the pharmacy chain operator forecast monetary yr 2024 revenue beneath Wall Avenue’s expectations.
Shares of the corporate rose 5% in early buying and selling, paring earlier premarket losses after it highlighted extra cost-cutting measures, like utilizing synthetic intelligence to make its provide chain extra environment friendly.
It’s also reducing its capital expenditure by about $600 million. Its shares have fallen almost 40% to this point this yr.
Walgreens has been contending with a steep drop in gross sales of COVID-19 merchandise, persistently weak prescription drug demand, reported walkouts by its retailer employees and weak gross sales of its shopper well being merchandise as a consequence of excessive inflation.
Its adjusted revenue of 67 cents per share within the fourth quarter additionally missed the LSEG estimate of 69 cents per share.
“Our efficiency this yr has not mirrored WBA’s robust property, model legacy, or our dedication to our prospects and sufferers,” Interim CEO Ginger Graham mentioned in a press release.
The corporate recorded a $6.8 billion pre-tax cost for opioid-related claims and litigation over the past monetary yr.
Walgreens had mentioned in June it could shut its shops at 150 places in the USA. It additionally named Tim Wentworth, a former Cigna (NYSE:) govt, as everlasting CEO on Tuesday.
The second-largest U.S. pharmacy chain operator, whose monetary yr ends in August, forecast an annual adjusted revenue of $3.20 to $3.50 per share, in comparison with analysts’ common estimate of $3.72 per share, in response to LSEG knowledge.
Within the fourth quarter, the corporate reported a 4.3% fall in U.S. retail gross sales and a 0.5% decline in whole prescriptions stuffed, together with vaccinations.
“Walgreens has misplaced buyer share in areas like magnificence and private care. A few of it is because costs stay too excessive and are uncompetitive – one thing increasingly more consumers received’t tolerate within the present surroundings,” GlobalData Managing Director Neil Saunders mentioned.
